Angioedema Related to Angiotensin-Converting Enzyme Inhibitors

Medicine (United States)

Volumn 94, Issue 45, 2015, Pages e1939-

  Javaud, Nicolas ^a   Achamlal, Jallal ^a   Reuter, Paul George ^b   Lapostolle, Frédéric ^b   Lekouara, Akim ^b,c   Youssef, Mustapha ^d   Hamza, Lilia ^b   Karami, Ahmed ^b   Adnet, Frédéric ^b   Fain, Olivier ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c Urgences   (France)

^d Hopital de Gonesse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CAPTOPRIL; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DIETHYLSTILBESTROL; ENALAPRIL; ICATIBANT; LISINOPRIL; PERINDOPRIL; RAMIPRIL; TRANDOLAPRIL; TRANEXAMIC ACID; VILDAGLIPTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; DIABETIC PATIENT; DISEASE SEVERITY; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; ANGIOEDEMA; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; SEVERITY OF ILLNESS INDEX;

AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84958159431     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001939     Document Type: Article

References (26)

1. Miller DR, Oliveria SA, Berlowitz DR, et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51:1624-1630.
2. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165:1637-1642.
3. Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906.
4. Blacher J, Halimi JM, Hanon O, et al. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol. 2014;28:1-9.
5. Marant C, Romon I, Fosse S, et al. French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes Metab. 2008;34:38-45.
6. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and casefatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
7. Bluestein HM, Hoover TA, Banerji AS, et al. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol. 2009;103:502-507.
8. Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100:327-332.
9. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359:1027-1036.
10. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci. 2001;46:1239-1243.
11. Rasmussen ER, Bygum A. ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate. BMJ Case Rep. 2013.
12. Nielsen EW, Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand. 2006;50:120-122.
13. Baş M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372: 418-425.
14. Bova M, Guilarte M, Sala-Cunill A, et al. Treatment of ACEIrelated angioedema with icatibant: a case series. Intern Emerg Med. 2015.
15. Javaud N, Fain O, Bernot B, et al. Bradykinin-mediated angioedema secondary to angiotensin converting enzyme: initiate treatment from the prehospital phase. Ann Fr Anesth Reanim. 2011;30:848-850.
16. Adnet F, Lapostolle F. International EMS systems: France. Resuscitation. 2004;63:7-9.
17. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602-616.
18. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.
19. Cicardi M, Zingale LC, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164:910-913.
20. Roberts JR, Lee JJ, Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol. 2012;109:774-775.
21. Javaud N, Karami A, Stirnemann J, et al. Bradykinin-mediated angioedema: factors prompting ED visits. Am J Emerg Med August. 2012.
22. Brown NJ, Byiers S, Carr D, et al. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension. 2009;54:516-523.
23. Zuraw BL, Bernstein JA, Lang DM, et al. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2013;131:1491-1493.
24. Javaud N, Lapostolle F, Sapir D, et al. The early treatment of bradykinin angioedema, a challenge for emergency medicine. Eur J Emerg Med Off J Eur Soc Emerg Med. 2013;20:291-292.
25. Rasmussen ER, Mey K, Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema: a dangerous new epidemic. Acta Derm Venereol. 2014;94:260-264.
26. Beltrami L, Zanichelli A, Zingale L, et al. Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens. 2011;29:2273-2277.